AAUM (Average Assets Under Management) of ₹534.15 Cr for Apr-Jun 2026 is the combined figure across Direct and Regular plans — sourced from AMFI India's quarterly disclosure. Equity Holdings above shows only the stock portion from the latest portfolio filing.
| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 71.4% | 71.2% | ▼ -0.2% |
| Healthcare Services | 26.5% | 25.1% | ▼ -1.4% |
| Chemicals & Petrochemicals | 0.0% | 1.8% | ▲ +1.8% |
| Healthcare Equipment & Supplies | 1.0% | 0.6% | ▼ -0.3% |
| Insurance | 0.2% | 0.0% | ▼ -0.2% |
| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 71.2% | 70.3% | ▼ -0.8% |
| Healthcare Services | 25.1% | 23.2% | ▼ -2.0% |
| Healthcare Equipment & Supplies | 0.6% | 4.7% | ▲ +4.1% |
| Chemicals & Petrochemicals | 1.8% | 1.5% | ▼ -0.3% |
Comparing Jul 2026 → Aug 2026
| # | Stock | Sector | Weight (Aug 2026) |
|---|---|---|---|
| 1 | Molbio Diagnostics Ltd. ₹34.76 Cr |
Healthcare Equipment & Supplies | 4.53% |
| 2 | Sequent Scientific Limited ₹15.42 Cr |
Pharmaceuticals & Biotechnology | 2.01% |
| 3 | Pfizer Limited ₹8.90 Cr |
Pharmaceuticals & Biotechnology | 1.16% |
| # | Stock | Sector | Jul 2026 | Aug 2026 | Change |
|---|---|---|---|---|---|
| 1 | Divi's Laboratories Limited ₹71.00 Cr |
Pharmaceuticals & Biotechnology | 8.26% | 9.25% | +0.99% |
| 2 | Apollo Hospitals Enterprise Limited ₹24.92 Cr |
Healthcare Services | 2.63% | 3.25% | +0.62% |
| 3 | Gland Pharma Limited ₹23.38 Cr |
Pharmaceuticals & Biotechnology | 2.75% | 3.04% | +0.29% |
| 4 | Yatharth Hospital & Trauma Care Serv Ltd ₹24.95 Cr |
Healthcare Services | 2.99% | 3.25% | +0.26% |
| 5 | Marksans Pharma Limited ₹19.30 Cr |
Pharmaceuticals & Biotechnology | 2.27% | 2.51% | +0.24% |
| 6 | Rubicon Research Limited ₹18.20 Cr |
Pharmaceuticals & Biotechnology | 2.18% | 2.37% | +0.19% |
| # | Stock | Sector | Jul 2026 | Aug 2026 | Change |
|---|---|---|---|---|---|
| 1 | Torrent Pharmaceuticals Limited ₹36.48 Cr |
Pharmaceuticals & Biotechnology | 6.16% | 4.75% | -1.41% |
| 2 | Sun Pharmaceutical Industries Limited ₹107.18 Cr |
Pharmaceuticals & Biotechnology | 14.88% | 13.96% | -0.92% |
| 3 | Max Healthcare Institute Limited ₹33.35 Cr |
Healthcare Services | 5.15% | 4.34% | -0.81% |
| 4 | Cipla Limited ₹28.18 Cr |
Pharmaceuticals & Biotechnology | 4.32% | 3.67% | -0.65% |
| 5 | Fortis Healthcare Limited ₹22.67 Cr |
Healthcare Services | 3.46% | 2.95% | -0.51% |
| 6 | Park Medi World Limited ₹25.79 Cr |
Healthcare Services | 3.86% | 3.36% | -0.50% |
| 7 | Krishna Institute Of Medical Sciences Limited ₹18.89 Cr |
Healthcare Services | 2.95% | 2.46% | -0.49% |
| 8 | EQ - LAXMI DENTAL LIMITED ₹1.27 Cr |
Healthcare Equipment & Supplies | 0.64% | 0.17% | -0.47% |
| 9 | Mankind Pharma Limited ₹21.77 Cr |
Pharmaceuticals & Biotechnology | 3.26% | 2.84% | -0.42% |
| 10 | Acutaas Chemicals Ltd ₹30.03 Cr |
Pharmaceuticals & Biotechnology | 4.32% | 3.91% | -0.41% |
35 stocks — Aug 2026
| # | Stock | Sector | Cap | Weight & Value |
|---|---|---|---|---|
| 1 |
₹107.18 Cr |
Pharmaceuticals & Biotechnology |
13.96%
|
|
| 2 |
₹71.00 Cr |
Pharmaceuticals & Biotechnology |
9.25%
|
|
| 3 |
₹36.48 Cr |
Pharmaceuticals & Biotechnology |
4.75%
|
|
| 4 |
₹34.76 Cr |
Healthcare Equipment & Supplies |
4.53%
|
|
| 5 |
₹33.35 Cr |
Healthcare Services |
4.34%
|
|
| 6 |
₹30.03 Cr |
Pharmaceuticals & Biotechnology |
3.91%
|
|
| 7 |
₹28.18 Cr |
Pharmaceuticals & Biotechnology |
3.67%
|
|
| 8 |
₹25.79 Cr |
Healthcare Services |
3.36%
|
|
| 9 |
₹24.92 Cr |
Healthcare Services |
3.25%
|
|
| 10 |
₹24.95 Cr |
Healthcare Services |
3.25%
|
Disclaimer: Data sourced from individual AMC monthly portfolio disclosures, as mandated by SEBI/AMFI. While we strive for accuracy, errors in parsing or presentation may occasionally occur. This is not investment advice. Please consult a SEBI-registered investment adviser before making any investment decisions.
Found a discrepancy or have feedback? Contact Us — we read every message personally.